30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

ICU Medical Inc (ICUI)

Track

In the last 90 days, ICU Medical Inc. saw a net insider selling of approximately $882,242, with executives contributing $584,308 to this net sell-off. A total of six transactions were recorded, all of which were sales, indicating a bearish sentiment among insiders. The company's stock has seen a modest 6.2% increase over the past 90 days.
Stock chart
Ticker: ICUI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DANIEL WOOLSON
Officer
1 sale — total 280,685 USD
Proposed sale 22 May 2026
Value US$577,818.61 | Price 308.11 | Shares 99,626
Sale 22 May 2026
Value US$143,267.04 | Price 433.02 | Shares 34,027
Sale 14 May 2026
Value US$303,623.76 | Price 124.08 | Shares 2,447
Proposed sale 14 May 2026
Value US$303,623.76 | Price 124.08 | Shares 2,447
Sale 12 May 2026
Value US$297,933.84 | Price 122.91 | Shares 2,424
Proposed sale 12 May 2026
Value US$297,933.84 | Price 122.91 | Shares 2,424
Proposed sale 25 Nov 2025
Value US$441,364.32 | Price 152.35 | Shares 2,897
Sale 25 Nov 2025
Value US$441,364.32 | Price 152.35 | Shares 2,897
Proposed sale 11 Nov 2025
Value US$132,380.85 | Price 142.35 | Shares 930
Proposed sale 11 Nov 2025
Value US$180,439.70 | Price 140.42 | Shares 1,285
Sale 11 Nov 2025
Value US$132,380.85 | Price 142.35 | Shares 930
Sale 11 Nov 2025
Value US$180,439.70 | Price 140.42 | Shares 1,285
Buy 27 Aug 2025
Value US$75,760.32 | Price 126.69 | Shares 598
Buy 27 Aug 2025
Value US$75,937.97 | Price 126.14 | Shares 602
Buy 14 Aug 2025
Value US$2,207,761.48 | Price 112.92 | Shares 19,551
Buy 14 Aug 2025
Value US$266,613.04 | Price 112.12 | Shares 2,378
Proposed sale 30 May 2025
Value US$93,537.08 | Price 133.62 | Shares 700
Sale 30 May 2025
Value US$93,537.08 | Price 133.62 | Shares 700
Sale 28 May 2025
Value US$640,576.49 | Price 128.50 | Shares 4,985
Sale 27 May 2025
Value US$647,795.00 | Price 131.00 | Shares 4,945
Sale 23 May 2025
Value US$644,670.00 | Price 130.00 | Shares 4,959
Sale 22 May 2025
Value US$644,832.16 | Price 130.03 | Shares 4,959
Sale 21 May 2025
Value US$653,961.00 | Price 133.00 | Shares 4,917
Sale 20 May 2025
Value US$667,878.88 | Price 137.11 | Shares 4,871
Sale 19 May 2025
Value US$83,352.54 | Price 138.92 | Shares 600
Proposed sale 19 May 2025
Value US$83,352.54 | Price 138.92 | Shares 600
Sale 19 May 2025
Value US$766,614.44 | Price 138.00 | Shares 5,555
Sale 16 May 2025
Value US$777,700.00 | Price 140.00 | Shares 5,555
Proposed sale 15 May 2025
Value US$274,714.20 | Price 137.36 | Shares 2,000
Sale 15 May 2025
Value US$274,714.20 | Price 137.36 | Shares 2,000
Sale 15 May 2025
Value US$752,977.47 | Price 135.55 | Shares 5,555
Sale 14 May 2025
Value US$770,323.84 | Price 138.65 | Shares 5,556
Proposed sale 14 May 2025
Value US$7,702,683.84 | Price 138.65 | Shares 55,556
Proposed sale 13 May 2025
Value US$278,992.38 | Price 143.66 | Shares 1,942
Sale 13 May 2025
Value US$278,992.38 | Price 143.66 | Shares 1,942
Proposed sale 2 Jan 2025
Value US$213,474.04 | Price 155.48 | Shares 1,373
Planned sale 2 Jan 2025
Value US$213,474.04 | Price 155.48 | Shares 1,373
Proposed sale 6 Dec 2024
Value US$350,158.49 | Price 156.25 | Shares 2,241
Sale 6 Dec 2024
Value US$350,158.49 | Price 156.25 | Shares 2,241
Proposed sale 2 Dec 2024
Value US$1,954,933.20 | Price 162.91 | Shares 12,000
Planned sale 2 Dec 2024
Value US$12,788.88 | Price 163.96 | Shares 78
Planned sale 2 Dec 2024
Value US$1,346,222.62 | Price 163.18 | Shares 8,250
Planned sale 2 Dec 2024
Value US$595,923.00 | Price 162.29 | Shares 3,672
Proposed sale 27 Nov 2024
Value US$153,683.21 | Price 158.11 | Shares 972
Sale 27 Nov 2024
Value US$153,683.21 | Price 158.11 | Shares 972
Sale 27 Nov 2024
Value US$225,936.28 | Price 158.00 | Shares 1,430
Sale 26 Nov 2024
Value US$32,979.06 | Price 160.09 | Shares 206
Sale 26 Nov 2024
Value US$1,195,211.62 | Price 159.09 | Shares 7,513
Sale 25 Nov 2024
Value US$331,726.33 | Price 169.08 | Shares 1,962
Proposed sale 25 Nov 2024
Value US$1,899,981.00 | Price 171.00 | Shares 11,111
Planned sale 1 Nov 2024
Value US$215,086.68 | Price 173.60 | Shares 1,239
Planned sale 1 Nov 2024
Value US$412,212.04 | Price 172.76 | Shares 2,386
Planned sale 1 Nov 2024
Value US$712,904.96 | Price 171.91 | Shares 4,147
Planned sale 1 Nov 2024
Value US$721,932.69 | Price 170.75 | Shares 4,228
Proposed sale 1 Nov 2024
Value US$2,062,135.20 | Price 171.84 | Shares 12,000
Proposed sale 1 Oct 2024
Value US$2,141,578.80 | Price 178.46 | Shares 12,000
Planned sale 1 Oct 2024
Value US$142,219.03 | Price 180.48 | Shares 788
Planned sale 1 Oct 2024
Value US$604,658.25 | Price 179.16 | Shares 3,375
Planned sale 1 Oct 2024
Value US$657,020.95 | Price 178.49 | Shares 3,681
Planned sale 1 Oct 2024
Value US$737,681.69 | Price 177.50 | Shares 4,156
Proposed sale 3 Sep 2024
Value US$1,961,539.20 | Price 163.46 | Shares 12,000
Planned sale 3 Sep 2024
Value US$624,298.15 | Price 164.07 | Shares 3,805
Planned sale 3 Sep 2024
Value US$726,326.28 | Price 163.59 | Shares 4,440
Planned sale 3 Sep 2024
Value US$610,915.97 | Price 162.69 | Shares 3,755
Proposed sale 30 Aug 2024
Value US$410,302.98 | Price 163.99 | Shares 2,502
Sale 30 Aug 2024
Value US$408,370.18 | Price 163.22 | Shares 2,502
Proposed sale 16 Aug 2024
Value US$1,872,480.00 | Price 156.04 | Shares 12,000
Planned sale 16 Aug 2024
Value US$1,872,480.00 | Price 156.04 | Shares 12,000
Proposed sale 13 Aug 2024
Value US$59,829,446.90 | Price 143.90 | Shares 415,771
Proposed sale 8 Aug 2024
Value US$295,426.00 | Price 144.11 | Shares 2,050
Planned sale 8 Aug 2024
Value US$295,425.91 | Price 144.11 | Shares 2,050
Proposed sale 16 Jul 2024
Value US$151,860,000.00 | Price 126.55 | Shares 1,200,000
Proposed sale 30 May 2024
Value US$1,291,517.00 | Price 103.00 | Shares 12,539
Sale 30 May 2024
Value US$212,328.35 | Price 104.49 | Shares 2,032
Sale 30 May 2024
Value US$1,091,156.15 | Price 103.85 | Shares 10,507
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-22 2026-05-22 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
99,626
308.11
US$577,819 		99,626 308.11 US$577,819
2026-05-22 2026-05-22 S Sale
2.9
Woolson Daniel

President

Officer
34,027 -43.2%
433.02
US$143,267 		34,027 -43.2% 433.02 US$143,267
2026-05-15 2026-05-14 S Sale
2.8
Sanzone Virginia Ruth

VP, General Counsel

Officer
76,305 +2.2%
346.74
US$1,602,565 		76,305 +2.2% 346.74 US$1,602,565
2026-05-14 2026-05-14 PrS Proposed sale
2.8
VIRGINIA SANZONE

Officer

Officer
2,447
124.08
US$303,624 		2,447 124.08 US$303,624
2026-05-13 2026-05-12 S Sale
2.2
Greenberg David C.
Non-Executive Director
2,424 -23.3%
122.91
US$297,934 		2,424 -23.3% 122.91 US$297,934
2026-05-12 2026-05-12 PrS Proposed sale
2.2
DAVID C GREENBERG

Director

Non-Executive Director
2,424
122.91
US$297,934 		2,424 122.91 US$297,934
2025-11-25 2025-11-25 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
2,897
152.35
US$441,364 		2,897 152.35 US$441,364
2025-11-25 2025-11-25 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,897 -20.4%
152.35
US$441,364 		2,897 -20.4% 152.35 US$441,364
2025-11-12 2025-11-11 PrS Proposed sale
2.8
VIRGINIA SANZONE

Officer

Officer
930
142.35
US$132,381 		930 142.35 US$132,381
2025-11-12 2025-11-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,285
140.42
US$180,440 		1,285 140.42 US$180,440
2025-11-12 2025-11-11 S Sale
2.8
Sanzone Virginia Ruth

VP, General Counsel

Officer
930 -14.6%
142.35
US$132,381 		930 -14.6% 142.35 US$132,381
2025-11-12 2025-11-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
1,285 -24.3%
140.42
US$180,440 		1,285 -24.3% 140.42 US$180,440
2025-08-27 2025-08-27 B Purchase
2.2
Greenberg David C.
Non-Executive Director
598 +8.1%
126.69
US$75,760 		598 +8.1% 126.69 US$75,760
2025-08-27 2025-08-27 B Purchase
2.2
Greenberg David C.
Non-Executive Director
602 +8.9%
126.14
US$75,938 		602 +8.9% 126.14 US$75,938
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
19,551 +17.7%
112.92
US$2,207,761 		19,551 +17.7% 112.92 US$2,207,761
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,378 +2.2%
112.12
US$266,613 		2,378 +2.2% 112.12 US$266,613
2025-05-30 2025-05-30 PrS Proposed sale
2.8
VIRGINIA SANZONE

Officer

Officer
700
133.62
US$93,537 		700 133.62 US$93,537
2025-05-30 2025-05-30 S Sale
2.8
Sanzone Virginia Ruth

VP, General Counsel

Officer
700 -9.9%
133.62
US$93,537 		700 -9.9% 133.62 US$93,537
2025-05-28 2025-05-28 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,985 -45.0%
128.50
US$640,576 		4,985 -45.0% 128.50 US$640,576
2025-05-28 2025-05-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,945 -47.3%
131.00
US$647,795 		4,945 -47.3% 131.00 US$647,795
2025-05-23 2025-05-23 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -50.3%
130.00
US$644,670 		4,959 -50.3% 130.00 US$644,670
2025-05-23 2025-05-22 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -53.5%
130.03
US$644,832 		4,959 -53.5% 130.03 US$644,832
2025-05-21 2025-05-21 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,917 -57.0%
133.00
US$653,961 		4,917 -57.0% 133.00 US$653,961
2025-05-21 2025-05-20 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,871 -61.3%
137.11
US$667,879 		4,871 -61.3% 137.11 US$667,879
2025-05-20 2025-05-19 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
600 -15.6%
138.92
US$83,353 		600 -15.6% 138.92 US$83,353
2025-05-19 2025-05-19 PrS Proposed sale
3.3
FINNEY ELISHA W

Director

Non-Executive Director
600
138.92
US$83,353 		600 138.92 US$83,353
2025-05-19 2025-05-19 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
138.00
US$766,614 		5,555 -69.9% 138.00 US$766,614
2025-05-19 2025-05-16 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
140.00
US$777,700 		5,555 -69.9% 140.00 US$777,700
2025-05-15 2025-05-15 PrS Proposed sale
2.1
Sousa Ben

Officer

Officer
2,000
137.36
US$274,714 		2,000 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
2.1
Sousa Ben

Chief Information Officer

Officer
2,000 -80.7%
137.36
US$274,714 		2,000 -80.7% 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
135.55
US$752,977 		5,555 -69.9% 135.55 US$752,977
2025-05-15 2025-05-14 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,556 -69.9%
138.65
US$770,324 		5,556 -69.9% 138.65 US$770,324
2025-05-14 2025-05-14 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
55,556
138.65
US$7,702,684 		55,556 138.65 US$7,702,684
2025-05-13 2025-05-13 PrS Proposed sale
2.2
Greenberg David C.

Director

Non-Executive Director
1,942
143.66
US$278,992 		1,942 143.66 US$278,992
2025-05-13 2025-05-13 S Sale
2.2
Greenberg David C.
Non-Executive Director
1,942 -22.3%
143.66
US$278,992 		1,942 -22.3% 143.66 US$278,992
2025-01-02 2025-01-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
1,373
155.48
US$213,474 		1,373 155.48 US$213,474
2025-01-02 2025-01-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,373 -1.3%
155.48
US$213,474 		1,373 -1.3% 155.48 US$213,474
2024-12-06 2024-12-06 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,241
156.25
US$350,158 		2,241 156.25 US$350,158
2024-12-06 2024-12-06 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,241 -17.1%
156.25
US$350,158 		2,241 -17.1% 156.25 US$350,158
2024-12-02 2024-12-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
162.91
US$1,954,933 		12,000 162.91 US$1,954,933
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
78 -0.1%
163.96
US$12,789 		78 -0.1% 163.96 US$12,789
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
8,250 -7.3%
163.18
US$1,346,223 		8,250 -7.3% 163.18 US$1,346,223
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,672 -3.1%
162.29
US$595,923 		3,672 -3.1% 162.29 US$595,923
2024-11-27 2024-11-27 PrS Proposed sale
2.2
Greenberg David C.

Director

Non-Executive Director
972
158.11
US$153,683 		972 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
2.2
Greenberg David C.
Non-Executive Director
972 -16.2%
158.11
US$153,683 		972 -16.2% 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,430 -100.0%
158.00
US$225,936 		1,430 -100.0% 158.00 US$225,936
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
206 -100.0%
160.09
US$32,979 		206 -100.0% 160.09 US$32,979
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
7,513 -97.3%
159.09
US$1,195,212 		7,513 -97.3% 159.09 US$1,195,212
2024-11-26 2024-11-25 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,962 -100.0%
169.08
US$331,726 		1,962 -100.0% 169.08 US$331,726
2024-11-25 2024-11-25 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
11,111
171.00
US$1,899,981 		11,111 171.00 US$1,899,981
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,239 -1.2%
173.60
US$215,087 		1,239 -1.2% 173.60 US$215,087
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,386 -2.2%
172.76
US$412,212 		2,386 -2.2% 172.76 US$412,212
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,147 -3.7%
171.91
US$712,905 		4,147 -3.7% 171.91 US$712,905
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,228 -3.6%
170.75
US$721,933 		4,228 -3.6% 170.75 US$721,933
2024-11-01 2024-11-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
171.84
US$2,062,135 		12,000 171.84 US$2,062,135
2024-10-01 2024-10-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
178.46
US$2,141,579 		12,000 178.46 US$2,141,579
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
788 -0.7%
180.48
US$142,219 		788 -0.7% 180.48 US$142,219
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,375 -3.1%
179.16
US$604,658 		3,375 -3.1% 179.16 US$604,658
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,681 -3.3%
178.49
US$657,021 		3,681 -3.3% 178.49 US$657,021
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,156 -3.6%
177.50
US$737,682 		4,156 -3.6% 177.50 US$737,682
2024-09-03 2024-09-03 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
163.46
US$1,961,539 		12,000 163.46 US$1,961,539
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,805 -3.5%
164.07
US$624,298 		3,805 -3.5% 164.07 US$624,298
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,440 -4.1%
163.59
US$726,326 		4,440 -4.1% 163.59 US$726,326
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,755 -3.5%
162.69
US$610,916 		3,755 -3.5% 162.69 US$610,916
2024-08-30 2024-08-30 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,502
163.99
US$410,303 		2,502 163.99 US$410,303
2024-08-30 2024-08-30 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,502 -16.0%
163.22
US$408,370 		2,502 -16.0% 163.22 US$408,370
2024-08-16 2024-08-16 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
156.04
US$1,872,480 		12,000 156.04 US$1,872,480
2024-08-16 2024-08-16 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
12,000 -10.3%
156.04
US$1,872,480 		12,000 -10.3% 156.04 US$1,872,480
2024-08-13 2024-08-13 PrS Proposed sale
2.0
Smiths Group International Holdings Ltd

Other
415,771
143.90
US$59,829,447 		415,771 143.90 US$59,829,447
2024-08-08 2024-08-08 PrS Proposed sale
2.8
VIRGINIA SANZONE

Officer

Officer
2,050
144.11
US$295,426 		2,050 144.11 US$295,426
2024-08-08 2024-08-08 PlS Planned sale
2.8
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,050 -31.4%
144.11
US$295,426 		2,050 -31.4% 144.11 US$295,426
2024-07-16 2024-07-16 PrS Proposed sale
2.0
Smiths Group International Holdings Limited

Other
1,200,000
126.55
US$151,860,000 		1,200,000 126.55 US$151,860,000
2024-05-30 2024-05-30 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
12,539
103.00
US$1,291,517 		12,539 103.00 US$1,291,517
2024-05-30 2024-05-30 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
2,032 -100.0%
104.49
US$212,328 		2,032 -100.0% 104.49 US$212,328
2024-05-30 2024-05-30 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
10,507 -83.8%
103.85
US$1,091,156 		10,507 -83.8% 103.85 US$1,091,156
Explore more

More insider trading research around ICU Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America